Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients

Blood

Volumn 98, Issue 4, 2001, Pages 906-912

  Soumelis, Vassili ^a,b,c,d   Scott, Lain ^a,b,c,d   Gheyas, Ferdous ^a,b,c,d   Bouhour, Damien ^a,b,c,d   Cozon, Gregoire ^a,b,c,d   Cotte, Laurent ^a,b,c,d   Huang, Laurence ^a,b,c,d   Levy, Jay A ^a,b,c,d   Liu, Yong Jun ^a,b,c,d  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HOSPICES CIVILS DE LYON   (France)

^d SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SURVIVAL; VIRUS LOAD; VIRUS REPLICATION;

EID: 0035883082     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.4.906     Document Type: Article

References (49)

1. Levy JA. HIV and the Pathogenesis of AIDS. 2nd ed. Washington, DC: American Society of Microbiology 1998.
2. + T cells. Science. 1992;257:383-387.
3. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-252.
4. Steinman RM, Granelli-Piperno A, Tenner-Racz K. Dendritic cells during infection with HIV-1 and SIV. In: Lotze MT, Thomson AW, eds. Dendritic Cells. New York, NY: Academic Press; 1999:421-434.
5. Geijtenbeek TB, Kwon DS, Torensma R, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000;100:587-597.
6. Knight SC, Patterson S. Bone marrow-derived dendritic cells, infection with human immunodeficiency virus, and immunopathology. Annu Rev Immunol. 1997;15:593-615.
7. Grassi F, Hosmalin A, McIlroy D, et al. Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. AIDS. 1999;13:759-766.
8. Koziel MJ, Dudley D, Wong JT, et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol. 1992;149:3339-3344.
9. Hayani KC, Verral SC, Pitrak DL. Impaired phagocyte oxidative capacity in human immunodeficiency virus-infected children. J Infect Dis. 1999;179:584-589.
10. Cameron ML, Granger DL, Matthews TJ, Weinberg JB. Human immunodeficiency virus (HIV)-infected human blood monocytes and peritoneal macrophages have reduced anticryptococcal activity whereas HIV-infected alveolar macrophages retain normal activity. J Infect Dis. 1994;170:60-67.
11. Biggs B-A, Hewish M, Kent S, Hayes K, Crowe SM. HIV-1 infection of human macrophages impairs phagocytosis and killing of Toxoplasma gondii. J Immunol. 1995;154:6132-6139.
12. Chaturvedi S, Newman SL. Modulation of the effector function of human macrophages for Histoplasma capsulatum by HIV-1. Role of the envelope glycoprotein gp120. J Clin Invest. 1997;100:1465-1474.
13. Thomas CA, Weinberger OK, Ziegler BL, et al. Human immunodeficiency virus-1 env impairs Fc receptor-mediated phagocytosis via a cyclic adenosine monophosphate-dependent mechanism. Blood. 1997;90:3760-3765.
14. Munoz JF, Salmen S, Berrueta LR, et al. Effect of human immunodeficiency virus type 1 on intracellular activation and superoxide production by neutrophils. J Infect Dis. 1999;180:206-210.
15. Brenner BG, Gryllis C, Gornitsky M, Wainberg MA. Changes in natural immunity during the course of HIV-1 infection. Clin Exp Immunol. 1993;93:142-148.
16. Ullum H, Gotzsche PC, Victor J, et al. Defective natural immunity: an early manifestation of human immunodeficiency virus infection. J Exp Med. 1995;182:789-799.
17. Bogdan C. The function of type I interferons in antimicrobial immunity. Curr Opin Immunol. 2000;12:419-424.
18. Yamamoto JK, Barre-Sinoussi F, Bolton V, Pedersen NC, Gardner MB. Human alpha- and beta-interferon but not gamma-suppress the in vitro replication of LAV, HTLV-III, and ARV-2. J Interferon Res. 1986;6:143-152.
19. Hartshorn KL, Neumeyer D, Vogt MW, Schooley RT, Hirsch MS. Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro. AIDS Res Hum Retroviruses. 1987;3:125-133.
20. Poll G, Orenstein JM, Kinter A, Folks TM, Fauci AS. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. Science. 1989;244:575-577.
21. Biron CA. Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol. 1997;9:24-34.
22. Sun S, Zhang X, Tough DF, Sprent J. Type I interferon-mediated stimulation of T cells by CpG DNA. J Exp Med. 1998;188:2335-2342.
23. Marrack P, Kappler J, Mitchell T. Type I interferons keep activated T cells alive. J Exp Med. 1999;189:521-530.
24. Cousens LP, Peterson R, Hsu S, et al. Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J Exp Med. 1999;189:1315-1328.
25. Hiroishi K, Tuting T, Lotze MT. IFN-alpha-expressing tumor cells enhance generation and promote survival of tumor-specific CTLs. J Immunol. 2000;164:567-572.
26. + T lymphocytes. J Immunol. 2000;164:6435-6443.
27. Lopez C, Fitzgerald PA, Siegal FP. Severe acquired immune deficiency syndrome in male homosexuals: diminished capacity to make interferon-alpha in vitro associated with severe opportunistic infections. J Infect Dis. 1983;148:962-966.
28. Siegal FP, Lopez C, Fitzgerald PA, et al. Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity. J Clin Invest. 1986;78:115-123.
29. Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999;284:1835-1837.
30. Cella M, Jarrossay D, Facchetti F, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999;5:919-923.
31. Grouard G, Rissoan MC, Filgueira L, et al. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand, J Exp Med. 1997;185:1101-1111.
32. Facchetti F, De Wolf-Peeters C, van den Oord JJ, De vos R, Desmet VJ. Plasmacytoid T cells: a cell population normally present in the reactive lymph node. An immunohistochemical and electronmicroscopic study. Hum Pathol. 1988;19:1085-1092.
33. + T cell demographics and dynamics in lymphatic tissues. Annu Rev Immunol. 1999;17:625-656.
34. Moore JP. Coreceptors: implications for HIV pathogenesis and therapy. Science. 1997;276:51-52.
35. Levy JA. HIV pathogenesis and long-term survival. AIDS. 1993;7:1401-1410.
36. Easterbrook PJ, Rostron T, Ives N, et al. Chemokine receptor polymorphisms and human immunodeficiency virus disease progression. J Infect Dis. 1999;180:1096-1105.
37. Magierowska M, Theodorou I, Debre P, et al. Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. Blood. 1999;93:936-941.
38. Clegg AO, Ashton LJ, Biti RA, et al. CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors. AIDS. 2000;14:103-108.
39. Carrington M, Nelson GW, Martin MP, et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science. 1999;283:1748-1752.
40. Migueles SA, Sabbaghian MS, Shupert WL, et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A. 2000;97:2709-2714.
41. Harrer T, Harrer E, Barbosa P, et al. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual. J Immunol. 1998;161:4875-4881.
42. Pontesilli O, Klein MR, Kerkhof-Garde SR, et al. Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection. J Infect Dis. 1998;178:1008-1018.
43. + cells correlates with the clinical state of HIV-infected individuals. Proc Natl Acad Sci U S A. 1996;93:13125-13130.
44. Barker E, Mackewicz CE, Reyes-Teran G, et al. Virological and immunological features of longterm human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. Blood. 1998;92:3105-3114.
45. de Quiros JC, Shupert WL, McNeil AC, et al. Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of non-progressors is mediated by CD8(+) T cells and associated with a proliferative response to p24 antigen. J Virol. 2000;74:2023-2028.
46. Sun R, Lin SF, Gradoville L, et al. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A. 1998;95:10866-10871.
47. Vieillard V, Jouveshomme S, Leflour N, et al. Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection. J Virol. 1999;73:10281-10288.
48. Arpinati M, Green CL, Heimfeld S, Heuser JE, Anasetti C. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood. 2000;95:2484-2490.
49. Maraskovsky E, Daro E, Roux E, et al. In vivo generation of human dendritic cell subsets by ft3 ligand. Blood. 2000;96:878-884.